Document is current

Article History

Received: 10 May 2023

Revised: 8 December 2023

Accepted: 19 December 2023

First Online: 8 January 2024

Competing interests

: PJ-F discloses honoraria as speaker from Astellas, Astra Zeneca, BMS, Lilly, MSD, Novartis, Roche. CLL discloses consulting/advisory role for Amgen, Roche, Sanofi, MSD, Merck, Servier, Bayer; research grants from Amgen, Roche, MSD, Merck, Servier and travel grants and/or congress support from Servier, Sanofi, Amgen, Roche, MSD, Merck. AFM discloses honoraria as speaker from Amgen, Astra Zeneca, Astra Zeneca, Eisai, Lilly, MSD, Pierre Fabre, Servier. AMLM discloses consulting/advisory role for Amgen, Bayer, Roche, Eisai; honoraria as speaker from Eisai, Lilly, Amgen, Bayer, Sanofi, Merck Serono, Roche, Bristol, Servier, Pierre Fabre; travel grants and/or congress support from Amgen, Roche, Servier. FVR discloses consulting/advisory role for MSD; honoraria from Roche, Servier, Lilly, Merck, Astra-Zeneca; travel grants and/or congress support from Merck, Roche, Servier. VA discloses advisory role for Amgen, Roche, Merck, Servier, Ipsen pharma, Novartis; travel grants and/or congress support from Merck. JA discloses consulting/advisory role for Merck; honoraria as speaker from Amgen, Merck and Servier; travel grants and/or congress support from Roche, Amgen, Merck, Servier and Sanofi. FS discloses consulting/advisory role for Merck Serono, Amgen; honoraria and travel grants and/or congress support from Hoffman La-Roche, Sanofi Aventis, Amgen, Merck Serono, Servier, Bristol-Myers Squibb and Terumo corporation. MG discloses travel grants and/or congress support from Roche, Amgen and Servier. AMC discloses consulting/advisory role for BMS, Sanofi and Novartis; honoraria as speaker from Roche, BMS, MSD, Novartis, Merck and Servier; travel grants and/or congress support from BMS, Novartis, Merck and Servier. RJM discloses honoraria as speaker from Servier, Sanofi, Pfizer and Pierre Fabre; travel grants and/or congress support from Merck. SCG discloses travel grants and/or congress support from Bristol Myers Squibb, MSD, Rovi, Amgem. BGA discloses consulting/advisory role for Sanofi; honoraria as speaker from Roche, BMS, Amgen MSD, Merck and Servier; travel grants and/or congress support from Amgen, Merck and Servier. PGV discloses consulting/advisory role for Servier, Amgen; travel grants and/or congress support from Merck, Sanofi, Amgen. ACVM discloses travel grants and/or congress support from Amgen, Merck, MSD, Roche, Sanofi, Servier. MMS discloses consulting/advisory role: Merck, Servier; honoraria as speaker from Amgen, Merck, Servier and Bayer; travel grants and/or congress support from Roche, Amgen, Merck, Servier. CCL discloses consulting/advisory role for Merck, honoraria as speaker from Amgen, Bayer, Sanofi, Merck Serono, Roche, Servier; travel grants and/or congress support from: Amgen, Bayer, Sanofi, Merck Serono, Roche, Servier. JAp discloses consulting/advisory role for Amgen, Bayer, Merck, Merck Sharp & Dohme, Pierre Fabre and Servier. AC-B discloses honoraria as speaker from Amgen, Astellas, Bayer, BMS, Eisai, Lilly, MSD, Merck, Novartis, Roche, Servier. DC-T, MCR, EAM, ABF-D, BA, and ACC have no conflict of interest, financial or otherwise, in relation to the scope of this work.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.